Glucosamine Sulfate Extra Strength
Natural health product licensed in Canada
- Other names
- GLS, GLS 750 mg, GLS Extra Strength 750 mg, Glucosamine Sulfate, Glucosamine Sulfate 750 mg
- Licence holder
- Assured Natural Distribution Inc.
- NPN or DIN-HM
- 80072925
- Status
- Active licence
- Licence date
- 6 October 2016
- Revision date
- 22 August 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de potassium | 750 milligramme | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Exosquelette de crevette | 750 milligramme | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Exosquelette de crabe | 750 milligramme | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Aspergillus niger - En entier | 750 milligramme | Not calculated |
Non-medicinal ingredients
Microcrystalline cellulose, NA, Gélatine, Stéarate de magnésium, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 1 Capsule | minimum: 2 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health. Helps protect against the deterioration of cartilage and relieve joint pain associated with osteoarthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80072925
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging